Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the regulatory approval by the Drugs Controller General of India (DCGI) to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine in the improvement of clinical outcomes during the treatment of COVID-19 patients.
- Read more about Anti-COVID drug Colchicine cleared for phase 2 clinical trials
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/anti-covid-drug-colchicine-cleared-for-phase-2-clinical-trials
No comments:
Post a Comment